Daptomycin as a possible new treatment option for surgical management of Methicillin-Resistant Staphylococcus aureus sternal wound infection after cardiac surgery.
We present a case of a 77-year old female who had undergone a coronary artery bypass grafting with an aortic valve replacement and developed three month later a Methicillin-Resistant Staphylococcus aureus (MRSA) sternal wound infection which was successful treated with Daptomycin combined with vacuum-assisted closure (VAC).
Popov
Aron F
AF
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany. Popov@med.uni-goettingen.de
Schmitto
Jan D
JD
Tirilomis
Theodor
T
Bireta
Christian
C
Coskun
Kasim O
KO
Mokashi
Suyog A
SA
Emmert
Alexander
A
Friedrich
Martin
M
Wiese
Christoph H
CH
Schoendube
Friedrich A
FA
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001021:Aortic Valve / Q000601:surgery; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D017576:Daptomycin / Q000627:therapeutic use*; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus; D054843:Negative-Pressure Wound Therapy; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy; D013249:Sternum / Q000382:microbiology / Q000601:surgery; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy
D000900:Anti-Bacterial Agents; D017576:Daptomycin